1890
H.-P. Jacquot de Rouville et al. / Tetrahedron 66 (2010) 1885–1891
purified by column chromatography (SiO2, CH2Cl2/hexane 1/1).
(1H, m, Hd); 8.03 (2H, m, Ho); 7.85 (1H, m, Hb); 7.60 (1H, m, Hc);
7.06 (2H, m, Hm); 3.92 (3H, s, OCH3); 13C NMR: (75 MHz, CDCl3)
Compound 3 was obtained as a yellow solid in 60% yield. MS (DCI/
NH3): 205.1 ([M]þ, calcd 205.1); 1H NMR: (300 MHz, CDCl3)
d
8.86
d
162.3; 147.5; 146.1; 127.3; 124.8; 123.4; 114.4; 112.5; 55.7; lmax
(1H, m, Hb); 8.80 (1H, s, Ha); 8.29 (1H, m, Hd); 7.71 (1H, t, J¼9 Hz,
(
3
) (CH2Cl2).
Hc); 2.85 (3H, s, He); 13C NMR: (75 MHz, CDCl3)
138.2; 129.1; 122.2; 121.0; 23.2.
d: 220.5; 171.3;
4.3.8. Dihydrobis(indazolyl)borate (8). Indazole (2 g, 16.93 mmol,
4 equiv) and potassium borohydride (228 mg, 4.22 mmol, 1 equiv)
were grinded in a mortar. The solid mixture was heated at 170 ꢀC
under an argon atmosphere until the expected volume of dihy-
drogen had been evolved, and the mixture was allowed to room
temperature. After sublimation and trituration in hot toluene, the
purified compound was stored in a dessicator. Compound 8 was
obtained as a white solid in 47% yield. MS (DCI/CH4): 247 ([MꢂK]ꢂ,
0
4.3.4. N-Acetyl-4-aminoindazole (4). Palladium on carbon (10%,
1.248 g, 1.17 mmol, 0.1 equiv) was added to a solution of N-acetyl-
4-nitroindazole (3) (2.4 g, 11.7 mmol, 1 equiv) in distilled THF
(250 mL) at room temperature. After stirring 12 h under a dihy-
drogen atmosphere, the mixture was filtered over Celite, evapo-
rated and purified by column chromatography (SiO2, CH2Cl2).
Compound 4 was obtained as an orange solid in 82% yield. MS (DCI
NH3): 176.09 ([MþH]þ, 100%, calcd 176.08); 1H NMR: (300 MHz,
100%, calcd 247); 1H NMR: (300 MHz, CDCl3)
d
7.33 (2H, dt, He ,
0
0
J¼8,5 Hz, J¼0.9 Hz); 7.32 (2H, d, Ha , J¼0.9 Hz); 7.08 (2H, dt, Hd ,
0
CDCl3)
d
8.07 (1H, s, Ha); 7.81 (1H, m, Hd); 7.33 (1H, m, Hc); 6.56 (1H,
J¼8 Hz, J¼1.1 Hz); 6.61 (2H, td, Hb , J¼8.5 Hz, J¼1.1 Hz); 6.38 (2H, td,
m, Hb); 4.18 (2H, s, NH2); 2.77 (3H, s, He); 13C NMR (CDCl3)
140.3; 139.9; 136.6; 131.0; 115.6 108.5; 105.6; 23.1.
d: 171.0;
Hc , J¼8.0 Hz, J¼0.9 Hz); 13C NMR: (75 MHz, CDCl3)
d: 143.3; 132.8;
0
131.5; 121.5; 120.5; 120.0; 112.1.
Microanalysis calculated for C14H12BN4K: C 58.76; H 4.23; N
19.58. Found: C 58.31; H 4.06; N 19.17.
4.3.5. N-Acetyl-4-((p-hydroxyphenyl)diazenyl)indazole
(5). Concentrated HCl (2.2 mL) at 0 ꢀC was added to a solution of
N-acetyl-4-amino-indazole (4) (1.24 g, 7.08 mmol, 1 equiv) in
a water/acetone mixture (60 mL, 1/1). A solution of sodium nitrite
(0.79 g, 13.3 mmol, 1.6 equiv) in water (20 mL) was added slowly.
After 15 min of stirring, phenol (0.67 g, 7.08 mmol, 1 equiv), sodium
hydroxide (0.43 g, 10.75 mmol, 1.5 equiv) and sodium carbonate
(1.07 g, 9.91 mmol, 1.4 equiv) dissolved in water (20 mL) were
added dropwise. The mixture was then stirred at 0 ꢀC for 2 h. After
evaporation of the solvent, the product was extracted with
dichloromethane and washed with a saturated NaCl solution. After
concentration in vacuum, the crude product was purified by col-
umn chromatography (SiO2, CH2Cl2/AcOEt 99/1). Compound 5 was
obtained as a yellow solid in 78% yield. MS (DCI/CH4): 281.09
4.3.9. Phenyl-4-((p-methoxyphenyl)diazenyl)indazolylbis(indazolyl)
borate cyclopentadienylruthenium (II) (9). In
equipped with a Teflon stopper, a 1 M solution of boron tri-
bromide in dichloromethane (39 L, 0.39 mmol, 1 equiv) was
added to trimethylsilylbenzene (68.5 L, 0.39 mmol, 1 equiv). Af-
a schlenk flask
m
m
ter 3 days at room temperature, solvent and bromotrimethylsilane
were evaporated under vacuum. The freshly synthesized dibro-
mophenylborane was dissolved in 3 mL of distilled benzene and
a solution of triethylamine (111.1 mL, 0.79 mmol, 2 equiv), indazole
(93.5 mg, 0.79 mmol, 1.5 equiv) and 4-(diazenyl(4-methox-
yphenyl))indazole (7) (100 mg, 0.36 mmol, 1 equiv) in 3 mL of
benzene was transferred via canula. The medium was stirred for
12 h at room temperature. The mixture was filtered under vacuum
to remove the colourless ammonium salt. A solution of potassium
tert-butoxide (44.4 mg, 0.36 mmol, 1 equiv) in 3 mL of THF/ben-
zene (1/1) was added and the medium was stirred for 12 addi-
tional hours under argon at 60 ꢀC. After evaporation of the
solvents, the mixture of tripodal ligands was extracted with ether.
The compounds were used without further purification. In
a schlenk flask, cyclopentadienyl tris(acetonitrile) ruthenium(II)
hexafluorophosphate (46 mg, 0.10 mmol, 1 equiv) was added un-
der argon to the mixture of tripodal ligands (65 mg, 0.10 mmol,
1 equiv) in 3 mL of anhydrous acetonitrile. The medium was stir-
red under reflux for 12 h. After evaporation of the solvent, the
crude material was purified by column chromatography
(SiO2$CH2Cl2/AcOEt 8/2). Compound 9 was obtained in 3% yield as
a green solid. MS (ESI): 740.10 ([MþH]þ, 100%, calcd 740.2); 1H
0
([MþH]þ, 100%, calcd 281.28); 1H NMR: (300 MHz, CDCl3)
d 8.80
(1H, s, Ha); 8.56 (1H, m, Hd); 7.98 (2H, m, Ho); 7.94 (1H, m, Hb); 7.71
(1H, dd, Hc); 7.02 (2H, m, Hm); 5.23 (1H, s, OH); 2.84 (3H, s, He); 13
NMR (CDCl3) : 171.4; 158.9; 149.9; 147.4; 139.7; 129.8; 125.2;
123.3; 118.2; 117.4; 115.9; 26.9; 23.2.
C
d
4.3.6. 1-Acetyl-4-((p-methoxyphenyl)diazenyl)indazole (6). Dried
potassium carbonate (23 g, 0.166 mol, 30 equiv) and N-acetyl-4-
(diazenyl(4-hydroxyhenyl))indazole (5) (1.54 g, 5.50 mmol,
1 equiv) were heated at 65 ꢀC in distilled THF (120 mL). A solu-
tion of iodomethane (1.0 mL, 16.5 mmol, 3 equiv) in distilled THF
(80 mL) was added dropwise. After stirring overnight at 65 ꢀC,
the solvent was evaporated and the crude product purified by
column chromatography (SiO2, CH2Cl2/cyclohexane 8/2). Com-
pound 6 was obtained as an orange solid in 74% yield. MS (DCI
/CH4): 295.12 ([MþH]þ, 100%, calcd 295.31); 1H NMR: (300 MHz,
NMR (CDCl3) d: 9.76 (1H, m, Ha); 7.72 (2H, m, Ha ); 7.61 (2H, m);
CDCl3)
(1H, m, Hb); 7.70 (1H, dd, Hc); 7.05 (2H, m, Hm); 3.82 (3H, s,
OCH3); 2.83 (3H, s, He); 13C NMR: (75 MHz, CDCl3)
:171.4; 162.6;
d
8.79 (1H, s, Ha); 8.54 (1H, m, Hd); 8.01 (2H, m, Ho); 7.94
7.55 (3H, m); 7.52 (3H, m); 7.35 (5H, m, BPh); 7.13 (4H, m); 6.91
(3H, m); 4.07 (5H, m, Cp); 3.91 (3H, m, OCH3) 162.8; 143.2; 139.7;
138.9; 138.7; 137.4; 137.1; 136.9; 136.2; 135.6; 134; 2122.7; 122.3;
d
147.2; 145.4; 140.2; 139.8; 129.8; 125.0; 123.2; 118.2; 117.4;
114.4; 55.6; 23.2.
119.3; 112.4; 111.0; 70.4; 36.4; 25.2; 54.7; UV lmax (3) (CH2Cl2)/nm:
261 (703), 272 (666), 295 (500), 384 (518).
4.3.7. 4-((p-Methoxyphenyl)diazenyl)indazole (7). To a solution of
sodium (780 mg, 3.41 mmol, 1 equiv) dissolved in dried methanol
(340 mL), 1-acetyl-4-(diazenyl(4-methoxyphenyl))indazole (6)
was added (1 g, 3.41 mmol, 1 equiv). After 20 min of stirring at
room temperature, the mixture was acidified to pH¼1 by addition
of aqueous HCl (5 M). After evaporation of the methanol, the
aqueous layer was extracted with dichloromethane. The organic
layers were washed with a saturated NaCl solution, dried over
sodium sulfate and then evaporated. Compound 7 was obtained as
an orange solid in 98% yield. MS (DCI /CH4): 253.10 ([MþH]þ, 100%,
Acknowledgements
This work was supported by the CNRS, the University Paul
Sabatier (Toulouse) and the European Community. H.-P.J.d.R.
thanks the French Ministry of National Education for a Ph.D. Fel-
´
lowship. Prof. J.-P. Launay and Dr. Andre Gourdon are thanked for
fruitful discussions. We also would like to thank Christine Viala for
her assistance and Garreth Thompson for preparation of starting
materials. Dr. Isabelle M. Dixon is warmly acknowledged for her
corrections and comments on this manuscript.
calcd 253.10); 1H NMR: (300 MHz, CDCl3)
d: 8.83 (1H, s, Ha); 8.54